Skip to main content
Julia Fehniger, MD, Obstetrics & Gynecology, Portland, OR, SUNY Downstate Health Sciences University

JuliaFehnigerMDFACOG(She/Her)

Obstetrics & Gynecology • Portland, OR

Gynecologic Oncology

Gynecologic Oncologist, Legacy Health

Join to view full profile

Dr. Fehniger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fehniger's full profile

Already have an account?

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Gynecologic Oncology, 2017 - 2020
  • University of Chicago
    University of ChicagoResidency, Obstetrics and Gynecology, 2013 - 2017
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2013

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2021 - 2025
  • WA State Medical License
    WA State Medical License 2021 - 2024
  • NY State Medical License
    NY State Medical License 2017 - 2022
  • IL State Medical License
    IL State Medical License 2013 - 2017
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Publications & Presentations

PubMed

Lectures

  • Genomic mutation profiles of paired ovarian cancers (OC) across time. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Most Women Treated in New York City for Gynecologic Cancers Are Not at Increased Risk of Death from COVID-19
    Most Women Treated in New York City for Gynecologic Cancers Are Not at Increased Risk of Death from COVID-19July 30th, 2020
  • Dr. Fehniger on Expanding PARP Inhibitors to Other Gynecologic Cancers
    Dr. Fehniger on Expanding PARP Inhibitors to Other Gynecologic CancersFebruary 9th, 2020
  • PARP Inhibitors May Have Benefit in BRCA-Mutant Endometrial Cancers
    PARP Inhibitors May Have Benefit in BRCA-Mutant Endometrial CancersFebruary 8th, 2020

Professional Memberships

Hospital Affiliations

Dr. Julia Fehniger, Dr. Julia Fehniger, MD, Dr. J Fehniger